Lipe & Dalton’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-48,598
| Closed | -$1.04M | – | 87 |
|
|
2017
Q2 | $1.04M | Hold |
48,598
| – | – | 0.68% | 41 |
|
|
2017
Q1 | $833K | Hold |
48,598
| – | – | 0.6% | 38 |
|
|
2016
Q4 | $871K | Sell |
48,598
-800
| -2% | -$14.3K | 0.62% | 38 |
|
|
2016
Q3 | $1.03M | Hold |
49,398
| – | – | 0.69% | 40 |
|
|
2016
Q2 | $1.33M | Buy |
49,398
+36,398
| +280% | +$979K | 0.92% | 37 |
|
|
2016
Q1 | $352K | Hold |
13,000
| – | – | 0.28% | 47 |
|
|
2015
Q4 | $378K | Hold |
13,000
| – | – | 0.31% | 45 |
|
|
2015
Q3 | $353K | Hold |
13,000
| – | – | 0.29% | 49 |
|
|
2015
Q2 | $356K | Sell |
13,000
-2,000
| -13% | -$54.8K | 0.26% | 49 |
|
|
2015
Q1 | $400K | Hold |
15,000
| – | – | 0.28% | 46 |
|
|
2014
Q4 | $317K | Hold |
15,000
| – | – | 0.21% | 52 |
|
|
2014
Q3 | $357K | Hold |
15,000
| – | – | 0.23% | 47 |
|
|
2014
Q2 | $346K | Hold |
15,000
| – | – | 0.22% | 47 |
|
|
2014
Q1 | $322K | Hold |
15,000
| – | – | 0.22% | 46 |
|
|
2013
Q4 | $277K | Hold |
15,000
| – | – | 0.19% | 50 |
|
|
2013
Q3 | $254K | Hold |
15,000
| – | – | 0.19% | 51 |
|
|
2013
Q2 | $232K | Buy |
+15,000
| New | +$232K | 0.19% | 46 |
|